NEW YORK — In a Healio Video Perspective from OSN New York, Aziz Mottiwala, of Tarsus Pharmaceuticals, discusses the FDA acceptance of the new drug application for TP-03 for the treatment of Demodex blepharitis.
Mottiwala also discusses the company’s “Look at the Lids” campaign to help educate specialists on diagnosing Demodex blepharitis.
The PDUFA target action date for TP-03 is Aug. 25, 2023.